| dc.citation.doi | doi:10.1016/j.autrev.2005.09.006 | en_US |
| dc.citation.epage | 92 | en_US |
| dc.citation.issue | 2 | en_US |
| dc.citation.jtitle | Autoimmunity Reviews | en_US |
| dc.citation.spage | 89 | en_US |
| dc.citation.volume | 5 | en_US |
| dc.contributor.author | Fleming, Sherry D. | |
| dc.contributor.author | Tsokos, George C. | |
| dc.contributor.authoreid | sdflemin | en_US |
| dc.date.accessioned | 2013-12-04T22:48:35Z | |
| dc.date.available | 2013-12-04T22:48:35Z | |
| dc.date.issued | 2013-12-04 | |
| dc.date.published | 2006 | en_US |
| dc.description.abstract | Activation of the classical complement pathway represents an effector mechanism of intestinal ischemia/reperfusion injury. Mice deficient in complement receptors 1 and 2 fail to produce a component of the natural antibody repertoire that binds to ischemia-conditioned tissues and activate complement. In contrast, mice prone to autoimmunity display accelerated and enhanced tissue injury that results from the binding of autoantibodies to injured tissues. Our experiments demonstrate that naturally occurring antibodies and autoantibodies mediate tissue injury only after an organ has been subjected to a stressor such as ischemia. | en_US |
| dc.identifier.uri | http://hdl.handle.net/2097/16953 | |
| dc.language.iso | en_US | en_US |
| dc.relation.uri | http://www.sciencedirect.com/science/article/pii/S156899720500159X | en_US |
| dc.subject | Natural antibodies | en_US |
| dc.subject | Tissue injury | en_US |
| dc.subject | Autoantibodies | en_US |
| dc.subject | Complement activation | en_US |
| dc.title | Complement, natural antibodies, autoantibodies and tissue injury | en_US |
| dc.type | Article (author version) | en_US |
English
العربية
বাংলা
Català
Čeština
Deutsch
Ελληνικά
Español
فارسی
Suomi
Français
Gàidhlig
ગુજરાતી
हिंदी
Magyar
Italiano
Қазақ
Latviešu
मराठी
Nederlands
Polski
Português
Português do Brasil
Русский
Srpski (lat)
Српски
Svenska
தமிழ்
Türkçe
Yкраї́нська
Tiếng Việt
繁体中文